13h
Clinical Trials Arena on MSNViiV to trial twice-yearly HIV antibody dosing after Phase IIb successThe company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.
It was later discovered that one of the donors was HIV positive, leading to her infection..HIV, AIDS, Cancer patient, RCC, Kerala High Court ...
Residents of Ensley now have a new resource for receiving free medical care, thanks to a new initiative by Alabama Regional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results